VANCOUVER, Aug. 30, 2019 /CNW/ - WELL Health
Technologies Corp. (TSX.V: WELL) (the "Company" or
"WELL"), a company focused on consolidating and modernizing
clinical and digital assets within the primary healthcare sector,
announces, further to its new release dated August 6, 2019, the Company received approval for
the issuance of 14,933 shares from the TSX Venture Exchange and
issued the shares on August 22, 2019.
These shares are issued in accordance with the acquisition
agreements announced on November
1st, 2018, whereby the Company acquired all of
the issued and outstanding shares of 13 target companies operating
an aggregate of 13 Healthcare Clinics in British Columbia. The shares are subject to a
statutory hold period expiring on the date that is 4 months and one
day after the date of issue.
WELL HEALTH TECHNOLOGIES CORP.
Per: "Hamed
Shahbazi"
Hamed Shahbazi
Chief Executive Officer, Chairman and Director
About WELL
WELL is a unique company that operates Primary Healthcare
Facilities as well as a significant EMR or Electronic Medical
Records business that supports the digitization of such
clinics. WELL's overarching objective is to empower doctors
to provide the best and most advanced care possible leveraging the
latest trends in digital health. WELL is publicly traded on
the TSX Venture Exchange under the symbol WELL.V. WELL was
recognized as a TSX Venture 50 Company in 2018 and 2019.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
SOURCE WELL Health Technologies Corp.